About Panexcell Clinical
Panexcell Clinical is a company based in Mumbai (India) founded in 1998. It operates as a B2B. The company has 32 employees as of March 31, 2024. Panexcell Clinical operates in a competitive market with competitors including SSI Strategy, Fusion Antibodies, Health Decisions, August Research and Phastar, among others.
- Headquarter Mumbai, India
- Employees 32 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Panexcell Clinical Lab Private Limited
- Date of Incorporation 20 Sep, 2006
- Jurisdiction Navi Mumbai, Maharashtra, India
-
Annual Revenue
$664.77 K (USD)-45.76as on Mar 31, 2024
-
Net Profit
-$101.44 K (USD)-1076.95as on Mar 31, 2024
-
EBITDA
-$18.67 K (USD)-106.64as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
32
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Panexcell Clinical
Detailed funding history for Panexcell Clinical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Panexcell Clinical
Investment portfolio details for Panexcell Clinical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Panexcell Clinical
Detailed financials for Panexcell Clinical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Panexcell Clinical Comparisons
Peer comparison for Panexcell Clinical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Panexcell Clinical
Panexcell Clinical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SSI Strategy, Fusion Antibodies, Health Decisions, August Research and Phastar, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance and medical affairs services are offered for drug development.
|
|
| Locked | Locked | Locked |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| Locked | Locked | Locked |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| Locked | Locked | Locked |
Clinical trial services are offered in Central and Eastern Europe.
|
|
| Locked | Locked | Locked |
Statistical consulting and data management for clinical trials are offered.
|
|
| Locked | Locked | Locked |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
Detailed competitors of Panexcell Clinical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Panexcell Clinical
Complete news archive for Panexcell Clinical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Panexcell Clinical
Panexcell Clinical was founded in 1998.
Panexcell Clinical is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Panexcell Clinical is 32.
Annual revenue of Panexcell Clinical is $664.77K as on Mar 31, 2024.
Panexcell Clinical, based in Mumbai, focuses on providing healthcare solutions, clinical research, cro services, and clinical trials. Offers CRO services for phase II to IV clinical trials and BABE studies. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Panexcell Clinical's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group.